Human osteopetroses and the osteoclast V-H+-ATPase acidification system

Frontiers in Bioscience

Volumn 10, Issue SUPPL. 3, 2005, Pages 2940-2954

  Ogbureke, Kalu U E ^a   Zhao, Qingxiao ^b,c   Li, Yi Ping ^b,c,d,e  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Zhejiang Cell Biomedical Research College   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d FORSYTH INSTITUTE   (United States)

^e HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Genetic mouse models; Human osteopetrosis; Osteoclast Medicated Acidification; Osteoclast V H+ ATPase; Osteopetrosis Associated Genes; Review

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CATHEPSIN K; VITRONECTIN RECEPTOR;

ACIDIFICATION; ALBERS SCHOENBERG DISEASE; AUTOSOMAL RECESSIVE DISORDER; CELL DIFFERENTIATION; ECTODERMAL DYSPLASIA; GENE CONTROL; GENETICS; GLANZMANN DISEASE; HUMAN; HUMAN PYCNODYSOSTOSIS; IATROGENIC DISEASE; LYMPHEDEMA; MUTATION; NONHUMAN; OSTEOCLAST; OSTEOSCLEROSIS; PHENOTYPE; PULMONARY HYPERTENSION; REVIEW; SKIN APPENDAGE DISEASE;

ANIMALIA;

EID: 21444438958     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1750     Document Type: Review

References (117)

1. E. H. Burger, J. W. Van der Meer, J. S. van de Gevel, J. C. Gribnau, G. W. Thesingh & R. van Furth In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes. J Exp. Med. 156, 1604-1614 (1982)
2. K. J. Ibbotson, G. D. Roodman, L. M. McManus & G. R. Mundy Identification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells. J Cell Biol 99, 471-80 (1984)
3. N. Kurihara, T. Suda, Y. Miura, H. Nakauchi, H. Kodama, K. Hiura, Y. Hakeda & M. Kumegawa Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood 74, 1295-302 (1989)
4. D. G. Walker Osteopetrosis cured by temporary parabiosis. Science 180, p. 875 (1973)
5. D. G. Walker Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science 190, 784-785 (1975)
6. J. I. Alvarez, S. L. Teitelbaum, H. C. Blair, E. M. Greenfield, N. A. Athanasou & F. P. Ross Generation of avian cells resembling osteoclasts from mononuclear phagocytes. Endocrinology 128, 2324-2335 (1991)
7. H. C. Blair & N. A. Athanasou Recent advances in osteoclast biology and pathological bone resorption. Histol. Histopathol. 19, 189-199 (2004)
8. N. Kurihara, C. Chenu, M. Miller, C. Civin & G. D. Roodman Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures. Endocrinology 126, 2733-41 (1990)
9. M. F. Pittenger, A. M. Mackay, S. C. Beck, R. K. Jaiswal, R. Douglas, J. D. Mosca, M. A. Moorman, D. W. Simonetti, S. Craig & D. R. Marshak Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147 (1999)
10. M. M. Tondravi, S. R. McKercher, K. Anderson, J. M. Erdmann, M. Quiroz, R. Maki & S. L. Teitelbaum Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386, 81-84 (1997)
11. Roth, P. Stanley E. R. The biology of CSF-1 and its receptor. Curr Top Microbiol Immunol 181, 141-67. 1992.
12. Galibert, L. Tometsko M. E. Anderson D. M. Cosman D. & Dougall W. C The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kB, a member of the TNFR superfamily. J.Biol.Chem. 273, 34120-34127. 1998.
13. William J.Boyle, W. Scott Simonet & David L. Lacey Osteoclast differentiation and activation. Nature 423, 337-342. 2004.
14. H. Takayanagi, S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Sahara, M. Isobe, T. Yokochi, J. Inoue, E. F. Wagner, T. W. Mak, T. Kodama & T. Taniguchi Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901 (2002)
15. S. L. Teitelbaum Bone resorption by osteoclasts. Science 289, 1504-1508 (2000)
16. I. A. Silver, R. J. Murrills & D. J. Etherington Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp. Cell Res. 175, 266-276 (1988)
17. H. K. Vaananen & M. Horton The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure. J Cell Sci. 108 (Pt 8), 2729-2732 (1995)
18. M. Chellaiah, N. Kizer, M. Silva, U. Alvarez, D. Kwiatkowski & K. A. Hruska Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength. J Cell Biol. 148, 665-678 (2000)
19. S. Kotake, N. Udagawa, N. Takahashi, K. Matsuzaki, K. Itoh, S. Ishiyama, S. Saito, K. Inoue, N. Kamatani, M. T. Gillespie, T. J. Martin & T. Suda IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin. Invest 103, 1345-1352 (1999)
20. M. Sato, T. A. Grese, J. A. Dodge, H. U. Bryant & C. H. Turner Emerging therapies for the prevention or treatment of postmenopausal osteoporosis. J Med. Chem. 42, 1-24 (1999)
21. B. S. Lee, L. S. Holliday, I. Krits & S. L. Gluck Vacuolar H+-ATPase activity and expression in mouse bone marrow cultures. J Bone Miner Res. 14, 2127-2136 (1999)
22. A. Mohn, R. Capanna, P. C. Delli, G. Morgese & F. Chiarelli Autosomal malignant osteopetrosis. From diagnosis to therapy. Minerva Pediatr. 56, 115-118 (2004)
23. R. Grossman & Z. Feldman, Bone growth causing ventriculoperitoneal shunt malfunction in a patient with osteopetrosis Case report. J Neurosurg. 100, 530-531 (2004)
24. W. McLean & B. R. Olsen Mouse models of abnormal skeletal development and homeostasis. Trends Genet. 17, p. S38-S43 (2001)
25. E. F. Wagner & G. Karsenty Genetic control of skeletal development. Curr. Opin. Genet. Dev. 11, 527-532 (2001)
26. E. Cleiren, O. Benichou, E. Van Hul, J. Gram, J. Bollerslev, F. R. Singer, K. Beaverson, A. Aledo, M. P. Whyte, T. Yoneyama, M. C. deVernejoul & W. Van Hul Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum. Mol. Genet. 10, 2861-2867 (2001)
27. R. Felix, M. G. Cecchini, W. Hofstetter, P. R. Elford, A. Stutzer & H. Fleisch Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Miner Res. 5, 781-789 (1990)
28. A. Frattini, P. J. Orchard, C. Sobacchi, S. Giliani, M. Abinun, J. P. Mattsson, D. J. Keeling, A. K. Andersson, P. Wallbrandt, L. Zecca, L. D. Notarangelo, P. Vezzoni & A. Villa Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat. Genet. 25, 343-346 (2000)
29. U. Kornak, D. Kasper, M. R. Bosl, E. Kaiser, M. Schweizer, A. Schulz, W. Friedrich, G. Delling & T. J. Jentsch Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104, 205-215 (2001)
30. M. F. S. P. M. J. C. M. M. C. &. S. M. Jr. Seifert Experimental studies of osteopetrosis in laboratory animals.. Clin Orthop 294, 23-33 (1999)
31. F. Shapiro Osteopetrosis. Current clinical considerations. Clin Orthop Relat Res. 34-44 (1993)
32. W. S. Sly, D. Hewett-Emmett, M. P. Whyte, Y. S. Yu & R. E. Tashian Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc. Natl. Acad. Sci. U. S. A 80, 2752-2756 (1983)
33. M. H. Helfrich, Osteoclast diseases. Microsc. Res. Tech. 61, 514-532 (2003)
34. N. Yarali, T. Fisgin, F. Duru & A. Kara Osteopetrosis and Glanzmann's thrombasthenia in a child. Ann. Hematol. 82, 254-256 (2003)
35. M. C. de Vernejoul & O. Benichou Human osteopetrosis and other sclerosing disorders: recent genetic developments. Calcif. Tissue Int. 69, 1-6 (2001)
36. H. C. Blair, C. W. Borysenko, A. Villa, P. H. Schlesinger, S. E. Kalla, B. B. Yaroslavskiy, V. Garcia-Palacios, J. I. Oakley & P. J. Orchard In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects. J Bone Miner Res. 19, 1329-1338 (2004)
37. A. Fasth & O. Porras Human malignant osteopetrosis: pathophysiology, management and the role of bone marrow transplantation. Pediatr. Transplant. 3 Suppl 1, 102-107 (1999)
38. K. A. Kasow, C. Bonfim, J. Asch, D. A. Margolis, J. Jenkins, R. F. Tamburro, R. Handgretinger & E. M. Horwitz Malignant infantile osteopetrosis and primary pulmonary hypertension: a new combination. Pediatr. Blood Cancer 42, 190-194 (2004)
39. E. J. Gerritsen, J. M. Vossen, I. H. van Loo, J. Hermans, M. H. Helfrich, C. Griscelli & A. Fischer Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. Pediatrics 93, 247-253 (1994)
40. F. Shapiro, L. L. Key & C. Anast Variable osteoclast appearance in human infantile osteopetrosis. Calcif. Tissue Int. 43, 67-76 (1988)
41. D. Stocker Osteopetrosis. Semin Musculoskelet Radiol 6, 229-305 (2002)
42. G. Cournot, C. L. Trubert-Thil, M. Petrovic, A. Boyle, C. Cormier, D. Girault, A. Fischer & M. Garabedian Mineral metabolism in infants with malignant osteopetrosis: heterogeneity in plasma 1,25-dihydroxyvitamin D levels and bone histology. J Bone Miner Res. 7, 1-10 (1992)
43. A. M. Flanagan, U. Sarma, C. G. Steward, A. Vellodi & M. A. Horton Study of the nonresorptive phenotype of osteoclast-like cells from patients with malignant osteopetrosis: a new approach to investigating pathogenesis. J Bone Miner Res. 15, 352-360 (2000)
44. A. Frattini, A. Pangrazio, L. Susani, C. Sobacchi, M. Mirolo, M. Abinun, M. Andolina, A. Flanagan, E. M. Horwitz, E. Mihci, L. D. Notarangelo, U. Ramenghi, A. Teti, J. Van Hove, D. Vujic, T. Young, A. Albertini, P. J. Orchard, P. Vezzoni & A. Villa Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J Bone Miner Res. 18, 1740-1747 (2003)
45. C. Sobacchi, A. Frattini, P. Orchard, O. Porras, I. Tezcan, M. Andolina, R. Babul-Hirji, I. Baric, N. Canham, D. Chitayat, S. Dupuis-Girod, I. Ellis, A. Etzioni, A. Fasth, A. Fisher, B. Gerritsen, V. Gulino, E. Horwitz, V. Klamroth, E. Lanino, M. Mirolo, A. Musio, G. Matthijs, S, Nonomaya, L. D. Notarangelo, H. D. Ochs, F. A. Superti, J. Valiaho, J. L. van Hove, M. Vihinen, D. Vujic, P. Vezzoni & A. Villa The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum. Mol. Genet. 10, 1767-1773 (2001)
46. Y. P. Li, W. Chen, Y. Liang, E. Li & P. Stashenko Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat. Genet. 23, 447-451 (1999)
47. C. Heaney, H. Shalev, K. Elbedour, R. Carmi, J. B. Staack, V. C. Sheffield & D. R. Beier Human autosomal recessive osteopetrosis maps to 11q13, a position predicted by comparative mapping of the murine osteosclerosis (oc) mutation. Hum. Mol. Genet. 7, 1407-1410 (1998)
48. U. Kornak, A. Schulz, W. Friedrich, S. Uhlhaas, B. Kremens, T. Voit, C. Hasan, U. Bode, T. J. Jentsch & C. Kubisch Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum. Mol. Genet. 9, 2059-2063 (2000)
49. T. Michigami, T. Kageyama, K. Satomura, M. Shima, K. Yamaoka, M. Nakayama & K. Ozono Novel mutations in the a3 subunit of vacuolar H(+)-adenosine triphosphatase in a Japanese patient with infantile malignant osteopetrosis. Bone 30, 436-439 (2002)
50. J. Tolar, S. L. Teitelbaum & P. J. Orchard Osteopetrosis. N. Engl. J Med. 351, 2839-2849 (2004)
51. S. G. Waguespack, D. L. Koller, K. E. White, T. Fishburn, G. Carn, K. A. Buckwalter, M. Johnson, M. Kocisko, W. E. Evans, T. Foroud & M. J. Econs Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II. J Bone Miner Res. 18, 1513-1518 (2003)
52. V. Rajapurohitam, N. Chalhoub, N. Benachenhou, L. Neff, R. Baron & J. Vacher The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function. Bone 28, 513-523 (2001)
53. P. Quarello, M. Forni, L. Barberis, C. Defilippi, M. F. Campagnoli, L. Silvestro, A. Frattini, N. Chalhoub, J. Vacher & U. Ramenghi Severe malignant osteopetrosis caused by a GL gene mutation. J Bone Miner Res. 19, 1194-1199 (2004)
54. E. J. Gerritsen, J. M. Vossen, A. Fasth, W. Friedrich, G. Morgan, A. Padmos, A. Vellodi, O. Porras, A. O'Meara & F. Porta Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group. J Pediatr. 125, 896-902 (1994)
55. M. P. Whyte Carbonic anhydrase II deficiency, Clin Orthop Relat Res. 52-63 (1993)
56. D. M. Fathallah, M. Bejaoui, W. S. Sly, R. Lakhoua & K. Dellagi A unique mutation underlying carbonic anhydrase II deficiency syndrome in patients of Arab descent. Hum. Genet. 94, 581-582 (1994)
57. P. Y. Hu, A. R. Ernst, W. S. Sly, P. J. Venta, L. A. Skaggs & R. E. Tashian Carbonic anhydrase II deficiency: single-base deletion in exon 7 is the predominant mutation in Caribbean Hispanic patients. Am. J Hum. Genet. 54, 602-608 (1994)
58. C. McMahon, A. Will, P. Hu, G. N. Shah, W. S. Sly & O. P. Smith Bone marrow transplantation corrects osteopetrosis in the carbonic anhydrase II deficiency syndrome. Blood 97, 1947-1950 (2001)
59. J. Bollerslev & P. E. Andersen, Jr. Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis. Bone 9, 7-13 (1988)
60. E. D. M. J. B. J. G. &. W. V. H. Van Hul Autosomal dominant osteopetrosis type I is genetically linked to the same region on human chromosome 11 as the high bone mass phenotype. J Bone Miner Res 15, p. S260 (2000)
61. E. Van Hul, J. Gram, J. Bollerslev, L. Van Wesenbeeck, D. Mathysen, P. E. Andersen, F. Vanhoenacker & W. Van Hul Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13. J Bone Miner Res. 17, 1111-1117 (2002)
62. M. L. Johnson, G. Gong, W. Kimberling, S. M. Recker, D. B. Kimmel & R. B. Recker Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13) Am. J Hum. Genet. 60, 1326-1332 (1997)
63. W. Van Hul Recent progress in the molecular genetics of sclerosing bone dysplasias. Pediatr. Pathol. Mol. Med. 22, 11-22 (2003)
64. J. Bollerslev Autosomal dominant osteopetrosis: bone metabolism and epidemiological, clinical, and hormonal aspects., Endocr. Rev. 10, 45-67 (1989)
65. A. B. Campos-Xavier, J. M. Saraiva, L. M. Ribeiro, A. Munnich & V. Cormier-Daire Chloride channel 7 (CLCN7) gene mutations in intermediate autosomal recessive osteopetrosis. Hum. Genet. 112, 186-189 (2003)
66. J. Bollerslev, S. C. Marks, Jr., S. Pockwinse, M. Kassem, K. Brixen, T. Steiniche & L. Mosekilde Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis. Bone 14, 865-869 (1993)
67. W. Van Hul, J. Bollerslev, J. Gram, E. Van Hul, W. Wuyts, O. Benichou, F. Vanhoenacker & P. J. Willems Localization of a gene for autosomal dominant osteopetrosis (Albers-Schonberg disease) to chromosome 1p21. Am. J Hum. Genet. 61, 363-369 (1997)
68. O. Benichou, E. Cleiren, J. Gram, J. Bollerslev, M. C. de Vernejoul & W. Van Hul Mapping of autosomal dominant osteopetrosis type II (Albers-Schonberg disease) to chromosome 16p13.3. Am. J Hum. Genet. 69, 647-654 (2001)
69. O. D. Benichou, B. Benichou, H. Copin, M. C. De Veraejoul & W. Van Hul Further evidence for genetic heterogeneity within type II autosomal dominant osteopetrosis. J Bone Miner Res 15, 1900-1904 (2000)
70. K. E. White, D. L. Koller, I. Takacs, K. A. Buckwalter, T. Foroud & M. J. Econs Locus heterogeneity of autosomal dominant osteopetrosis (ADO) J Clin Endocrinol Metab 84, 1047-1051 (1999)
71. B. D. Gelb, G. P. Shi, H. A. Chapman & R. J. Desnick Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273, 1236-1238 (1996)
72. K. P. McHugh, K. Hodivala-Dilke, M. H. Zheng, N. Namba, J. Lam, D. Novack, X. Feng, F. P. Ross, R. O. Hynes & S. L. Teitelbaum Mice lacking beta3 integrals are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105, 433-440 (2000)
73. X. Feng, D. V. Novack, R. Faccio, D. S. Ory, K. Aya, M. I. Boyer, K. P. McHugh, F. P. Ross & S. L. Teitelbaum A Glanzmann's mutation in beta 3 integral specifically impairs osteoclast function. J Clin Invest 107, 1137-1144 (2001)
74. C. G. Steward, I. Pellier, A. Mahajan, M. T. Ashworth, A. G. Stuart, A. Fasth, D. Lang, A. Fischer, W. Friedrich and A. S. Schulz Severe pulmonary hypertension: a frequent complication of stem cell transplantation for malignant infantile osteopetrosis. Br. J Haematol. 124, 63-71 (2004)
75. S. Dupuis-Girod, N. Corradini, S. Hadj-Rabia, J. C. Fournet, L. Faivre, F. Le Deist, P. Durand, R. Doffinger, A. Smahi, A. Israel, G. Courtois, N. Brousse, S. Blanche, A. Munnich, A. Fischer, J. L. Casanova & C. Bodemer Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics 109, p. e97 (2002)
76. M. P. Whyte, D. Wenkert, K. L. Clements, W. H. McAlister & S. Mumm Bisphosphonate-induced osteopetrosis. N. Engl. J Med. 349, 457-463 (2003)
77. S. L. Gluck, D. M. Underhill, M. Iyori, L. S. Holliday, T. Y. Kostrominova & B. S. Lee Physiology and biochemistry of the kidney vacuolar H+-ATPase. Annu. Rev. Physiol 58, 427-445 (1996)
78. H. C. Blair, S. L. Teitelbaum, R. Ghiselli & S. Gluck Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 245, 855-857 (1989)
79. S. B. Peng, X. Li, B. P. Crider, Z. Zhou, P. Andersen, S. J. Tsai, X. S. Xie & D. K. Stone Identification and reconstitution of an isoform of the 116-kDa subunit of the vacuolar proton translocating ATPase. J Biol. Chem. 274, 2549-2555 (1999)
80. Z. Zhou, S. B. Peng, B. P. Crider, C. Slaughter, X. S. Xie & D. K. Stone Molecular characterization of the 50- and 57-kDa subunits of the bovine vacuolar proton pump. J Biol. Chem. 273, 5878-5884 (1998)
81. Z. Zhou, S. B. Peng, B. P. Crider, P. Andersen, X. S. Xie & D. K. Stone Recombinant SFD isoforms activate vacuolar proton pumps. J Biol. Chem. 274, 15913-15919 (1999)
82. T. Toyomura, T. Oka, C. Yamaguchi, Y. Wada & M. Futai Three subunit a isoforms of mouse vacuolar H(+)-ATPase. Preferential expression of the a3 isoform during osteoclast differentiation. J Biol. Chem. 275, 8760-8765 (2000)
83. W. Deng, P. Stashenko, W. Chen, Y. Liang, K. Shimizu & Y. P. Li Characterization of mouse Atp6i gene, the gene promoter, and the gene expression. J Bone Miner Res. 16, 1136-1146 (2001)
84. Y. P. Li, W. Chen & P. Stashenko Molecular cloning and characterization of a putative novel human osteoclast-specific 116-kDa vacuolar proton pump subunit. Biochem. Biophys. Res. Commun. 218, 813-821 (1996)
85. J. C. Scimeca, A. Franchi, C. Trojani, H. Parrinello, J. Grosgeorge, C. Robert, O. Jaillon, C. Poirier, P. Gaudray & G. F. Carle The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 26, 207-213 (2000)
86. N. Utku, T. Heinemann, S. G. Tullius, G. C. Bulwin, S. Beinke, R. S. Blumberg, F. Beato, J. Randall, R. Kojima, L. Busconi, E. S. Robertson, R. Schulein, H. D. Volk, E. L. Milford & S. R. Gullans Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein. Immunity. 9, 509-518 (1998)
87. T. Heinemann, G. C. Bulwin, J. Randall, B. Schnieders, K. Sandhoff, H. D. Volk, E. Milford, S. R. Gullans & N. Utku Genomic organization of the gene coding for TIRC7, a novel membrane protein essential for T cell activation. Genomics 57, 398-406 (1999)
88. S. B. Peng, B. P. Crider, X. S. Xie & D. K. Stone Alternative mRNA splicing generates tissue-specific isoforms of 116-kDa polypeptide of vacuolar proton pump. J Biol. Chem. 269, 17262-17266 (1994)
89. M. S. Perin, V. A. Fried, D. K. Stone, X. S. Xie & T. C. Sudhof Structure of the 116-kDa polypeptide of the clathrin-coated vesicle/synaptic vesicle proton pump. J Biol. Chem. 266, 3877-3881 (1991)
90. J. P. Mattsson, C. Skyman, H. Palokangas, K. H. Vaananen & D. J. Keeling Characterization and cellular distribution of the osteoclast ruffled membrane vacuolar H+-ATPase B-subunit using isoform-specific antibodies. J Bone Miner Res. 12, 753-760 (1997)
91. J. P. Mattsson, P. H. Schlesinger, D. J. Keeling, S. L. Teitelbaum, D. K. Stone & X. S. Xie Isolation and reconstitution of a vacuolar-type proton pump of osteoclast membranes. J Biol. Chem. 269, 24979-24982 (1994)
92. Y. P. Li, M. Alexander, A. L. Wucherpfennig, P. Yelick, W. Chen & P. Stashenko Cloning and complete coding sequence of a novel human cathepsin expressed in giant cells of osteoclastomas. J Bone Miner Res 10, 1197-1202 (1995)
93. G. P. Shi, H. A. Chapman, S. M. Bhairi, C. DeLeeuw, V. Y. Reddy & S. J. Weiss Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2. FEBS Lett. 357, 129-134 (1995)
94. T. Inaoka, G. Bilbe, O. Ishibashi, K. Tezuka, M. Kumegawa & T. Kokubo Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone. Biochem. Biophys. Res Commun. 206, 89-96 (1995)
95. D. Bromme & K. Okamoto Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution. Biol. Chem. Hoppe Seyler 376, 379-384 (1995)
96. K. Tezuka, Y. Tezuka, A. Maejima, T. Sato, K. Nemoto, H. Kamioka, Y. Hakeda & M. Kumegawa Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J Biol. Chem. 269, 1106-1109 (1994)
97. Y. P. Li, M. Alexander, A. L. Wucherpfennig, P. Yelick, W. Chen & P. Stashenko Cloning and complete coding sequence of a novel human cathepsin expressed in giant cells of osteoclastomas. J Bone Miner Res 10, 1197-1202 (1995)
98. F. H. Drake, R. A. Dodds, I. E. James, J. R. Connor, C. Debouck, S. Richardson, E. Lee-Rykaczewski, L. Coleman, D. Rieman, R. Barthlow, G. Hastings & M. Gowen Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol. Chem. 271, 12511-12516 (1996)
99. D. Bromme, K. Okamoto, B. B. Wang & S. Biroc Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol. Chem. 271, 2126-2132 (1996)
100. L. T. Duong, P. Lakkakorpi, I. Nakamura & G. A. Rodan Integrins and signaling in osteoclast function. Matrix Biol. 19, 97-105 (2000)
101. F. A. van der & A. Sonnenberg Function and interactions of integrins. Cell Tissue Res 305, 285-298 (2001)
102. B. P. Eliceiri Integrin and growth factor receptor crosstalk. Circ. Res 89, 1104-1110 (2001)
103. L. T. Duong, P. Lakkakorpi, I. Nakamura & G. A. Rodan Integrins and signaling in osteoclast function. Matrix Biol. 19, 97-105 (2000)
104. S. C. Marks, Jr., M. F. Seifert & P. W. Lane Osteosclerosis, a recessive skeletal mutation on chromosome 19 in the mouse. J Hered. 76, 171-176 (1985)
105. M. F. Seifert & S. C. Marks, Jr. Congenitally osteosclerotic (oc/oc) mice are resistant to cure by transplantation of bone marrow or spleen cells from normal littermates. Tissue Cell 19, 29-37 (1987)
106. M. Gowen, F. Lazner, R. Dodds, R. Kapadia, J. Feild, M. Tavaria, I. Bertoncello, F. Drake, S. Zavarselk, I. Tellis, P. Hertzog, C. Debouck & I. Kola Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res 14, 1654-1663 (1999)
107. P. Saftig, E. Hunziker, O. Wehmeyer, S. Jones, A. Boyde, W. Rommerskirch, J. D. Moritz, P. Schu & K. von Figura Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl. Acad. Sci. U. S. A 95, 13453-13458 (1998)
108. W. D. W. L. Y.-P. Chen Cellular and molecular basis of cathepsin K-deficient mice that exhibit osteopetrosis, craniofacial dysplasia, and acroosteolysis. J. Dent. Res. 79, p. 603 (2000)
109. W. Wiktor-Jedrzejczak, A. Bartocci, A. W. Ferrante, Jr., A. Ahmed-Ansari, K. W. Sell, J. W. Pollard & E. R. Stanley Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. U. S. A 87, 4828-4832 (1990)
110. A. E. Grigoriadis, Z. Q. Wang, M. G. Cecchini, W. Hofstetter, R. Felix, H. A. Fleisch & E. F. Wagner c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443-448 (1994)
111. M. A. Lomaga, W. C. Yeh, I. Sarosi, G. S. Duncan, C. Furlonger, A. Ho, S. Morony, C. Capparelli, G. Van, S. Kaufinan, H. A. van der, A. Itie, A. Wakeham, W. Khoo, T. Sasaki, Z. Cao, J. M. Penninger, C. J. Paige, D. L. Lacey, C. R. Dunstan, W. J. Boyle, D. V. Goeddel & T. W. Mak TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13, 1015-1024 (1999)
112. V. Iotsova, J. Caamano, J. Loy, Y. Yang, A. Lewin & R. Bravo Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat. Med. 3, 1285-1289 (1997)
113. C. E. Dent, J. M. Smellie & L. Watson Studies in osteopetrosis, Arch. Dis. Child 40, 7-15 (1965)
114. M. S. Kocher & J. R. Kasser Osteopetrosis. Am. J Orthop 32, 222-228 (2003)
115. M. Gowen, F. Lazner, R. Dodds, R. Kapadia, J. Feild, M. Tavaria, I. Bertoncello, F. Drake, S. Zavarselk, I. Tellis, P. Hertzog, C. Debouck & I. Kola Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res 14, 1654-1663 (1999)
116. W. Wiktor-Jedrzejczak, A. Bartocci, A. W. Ferrante, Jr., A. Ahmed-Ansari, K. W. Sell, J. W. Pollard & E. R. Stanley Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. U. S. A 87, 4828-4832 (1990)
117. W. C. Dougall, M. Glaccum, K. Charrier, K. Rohrbach, K. Brasel, T. De Smedt, E. Daro, J. Smith, M. E. Tometsko, C. R. Maliszewski, A. Armstrong, V. Shen, S. Bain, D. Cosman, D. Anderson, P. J. Morrissey, J. J. Peschon & J. Schuh RANK is essential for osteoclast and lymph node development. Genes Dev. 13, 2412-2424 (1999)